Yamanaka, Taro
Takemura, Kohji
Hayashida, Michikata
Suyama, Koichi
Urakami, Shinji
Miura, Yuji http://orcid.org/0000-0002-7091-628X
Article History
Received: 31 January 2023
Accepted: 13 June 2023
First Online: 28 June 2023
Declarations
:
: There are no conflicts of interest to declare except for Yuji Miura: personal fees from Ono Pharmaceutical, Bristol Myers Squibb, MSD, and Takeda; Advisory Board personal member of Chugai Pharmaceutical Co. and Takeda; local PI and institutional financial interests from MSD and Ono Pharmaceutical. All of these were outside the submitted work.